Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Melanoma 3Uveal Melanoma 2Neoplasms 2Lymphoma, B-Cell 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcopenia 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Lymphoma, Follicular 1Gastrointestinal Stromal Tumors 1Esophageal Squamous Cell Carcinoma 1Efficacy, Team 1Diabetes Mellitus, Insulin-Dependent, 12 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Chondrosarcoma 1Carcinoma, Renal Cell 1Bone Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

spartalizumab 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Desmoplastic Small Round Cell Tumor × Nivolumab × Clear all
NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
60 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡